ダウンロード数: 197
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| j.jcte.2019.100207.pdf | 743.85 kB | Adobe PDF | 見る/開く |
| タイトル: | Graves’ disease and mental disorders |
| 著者: | Fukao, Atsushi Takamatsu, Junta Arishima, Takeshi Tanaka, Mika Kawai, Toshio  Okamoto, Yasuki Miyauchi, Akira Imagawa, Akihisa |
| 著者名の別形: | 河合, 俊雄 |
| キーワード: | Graves’ disease Mental disorder Depressive disorder Anxiety disorder Eating disorder Stress |
| 発行日: | Mar-2020 |
| 出版者: | Elsevier Inc. |
| 誌名: | Journal of Clinical & Translational Endocrinology |
| 巻: | 19 |
| 論文番号: | 100207 |
| 抄録: | Mental disorders merge highly with thyroid diseases. Because of its regulatory effects on serotonin and noradrenalin, T3 has been linked closely to depression and anxiety. It has known that in many cases, the mental symptoms persist even after normalization of thyroid function by treatment. Psychosocial factors including stress have been associated with mental symptoms even after thyroid function normalization in Graves’ disease and a combination of mental disorders have been related to the exacerbation of hyperthyroidism. These findings suggest that psychosomatic approaches based on the bio-psycho-social medical model are important for the treatment of mental disorders associated with Graves’ disease. |
| 著作権等: | © 2019 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/BY-NC-ND/4.0/). |
| URI: | http://hdl.handle.net/2433/245480 |
| DOI(出版社版): | 10.1016/j.jcte.2019.100207 |
| PubMed ID: | 31763175 |
| 出現コレクション: | 学術雑誌掲載論文等 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。